- Rank in Search Criteria: 4141
World Rank (Jan-05-2024): 13,679
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 13952
Market Cap (Jul-30-2023): 0.41 Billion USD
World Rank (Jan-2022): 13,085
Market Cap (Jan-2022): 0.53 Billion USDHeadquarters Country: USA Annual Revenue in USD: 111 Million USD
Annual Net Income in USD: 111 Million USD
Annual Results for Period ending: May-2022 ending year
- Rank in Search Criteria: 4142
World Rank (Jan-05-2024): 13,685
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 15237
Market Cap (Jul-30-2023): 0.34 Billion USD
World Rank (Jan-2022): 16,224
Market Cap (Jan-2022): 0.32 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -46 Million USD
Annual Results for Period ending: Apr-2021 ending yearCompany Profile: KalVista Pharmaceuticals is a Pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need. The company annual revenue is 12.7 million USD and 56 employees as on 2020. The headquarters is in USA.
- Rank in Search Criteria: 4143
World Rank (Jan-05-2024): 13,698
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 14149
Market Cap (Jul-30-2023): 0.40 Billion USD
World Rank (Jan-2022): 12,540
Market Cap (Jan-2022): 0.58 Billion USDHeadquarters Country: USA Annual Revenue in USD: 102 Million USD
Annual Net Income in USD: 102 Million USD
Annual Results for Period ending: Jul-2021 ending year
- Rank in Search Criteria: 4144
World Rank (Jan-05-2024): 13,705
World Rank (Jul-30-2023): 13705
Market Cap (Jul-30-2023): 0.41 Billion USD
World Rank (Jan-2022): 15,073
Market Cap (Jan-2022): 0.39 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4145
World Rank (Jan-05-2024): 13,707
World Rank (Jul-30-2023): 13707
World Rank (Jan-2022): 13,707
Headquarters Country: USA
- Rank in Search Criteria: 4146
World Rank (Jan-05-2024): 13,716
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 13979
Market Cap (Jul-30-2023): 0.41 Billion USD
World Rank (Jan-2022): 12,982
Market Cap (Jan-2022): 0.54 Billion USDHeadquarters Country: USA Annual Revenue in USD: 101 Million USD
Annual Net Income in USD: 101 Million USD
Annual Results for Period ending: Jul-2021 ending year
- Rank in Search Criteria: 4147
World Rank (Jan-05-2024): 13,720
World Rank (Jul-30-2023): 13720
Market Cap (Jul-30-2023): 0.43 Billion USD
World Rank (Jan-2022): 15,026
Market Cap (Jan-2022): 0.39 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4148
World Rank (Jan-05-2024): 13,720
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 16013
Market Cap (Jul-30-2023): 0.29 Billion USD
World Rank (Jan-2022): 21,653
Market Cap (Jan-2022): 0.12 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4149
World Rank (Jan-05-2024): 13,734
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 14108
Market Cap (Jul-30-2023): 0.40 Billion USD
Company Profile: Sundial Growers is a consumer packaged goods and applying them to the cannabis industries company. The company annual revenue is 56 million CAD for year ending December 2021. The headquarters is in Canada.
SUNDIAL GROWERS changed it's name to SNDL INC.
- Rank in Search Criteria: 4150
World Rank (Jan-05-2024): 13,737
Market Cap (Jan-05-2024): 0.42 Billion USD
World Rank (Jul-30-2023): 12997
Market Cap (Jul-30-2023): 0.48 Billion USD
World Rank (Jan-2022): 12,137
Market Cap (Jan-2022): 0.62 Billion USDAnnual Revenue in USD: 89 Million USD
Annual Net Income in USD: 32 Million USD
Annual Results for Period ending: Dec-2021 ending year